BioLife Solutions
- Market cap
- 1.89B
- P/E (TTM)i
- 32.72
- P/Bi
- 4.50
- EPSi
- -0.10
- Div yieldi
- 0.00%
- 52W posi
- 95%
Anonymous reader poll. Unscientific, not investment advice.
BioLife Solutions last traded at 38.61, little changed on the session. That leaves the company valued at approximately 1.89B, the #2844 most valuable US-listed company we track. Wall Street's 6-analyst consensus lands on Hold, with a price target averaging 31.00 (-20% from here). Over the past year the stock has ranged from 17.86 to 39.76; it now sits 95% up that band.
✦ StockVane Quant Insights how this is computed
- Twelve-month momentum in the top 19% of the universe, above its 200-day average.
- Signal has read BUY for 3 weeks.
- Its last 4 Buy calls have actually lost 11% on average three months out - the strategy's edge here has come from the basket, not from this ticker.
- Recent price momentum is +41.3% on average (3-month/1-year).
- Short interest has risen to 7.9% of float.
- Analyst tilt is Hold.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 38.61
- Open
- 0.00
- Day range
- 0.00 - 0.00
- Avg price
- 0.00
- Volume
- 0
- Turnover
- 0
- Turnover ratei
- 0.00%
- Volume ratioi
- 0.00
- Amplitudei
- 0.00%
- 52-week rangei
- 17.86 - 39.76
Valuation
- P/Ei
- -386.10
- P/E (TTM)i
- 32.72
- P/Bi
- 4.50
- EPSi
- -0.10
- Book value / shi
- 8.59
- Net profit
- -4.89M
- Net assets
- 420.01M
Share structure
- Market cap
- 1.89B
- Float capi
- 1.55B
- Shares out
- 48.92M
- Float sharesi
- 40.14M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
2.9% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-21.36M net over the window
Short interest
- Shares short
- 3.88M
- % of floati
- 7.94%
- Days to coveri
- 4.49
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of BioLife Solutions (BLFS)?
BioLife Solutions last traded at 38.61. The quote on this page refreshes every few seconds while US markets are open.
What is BioLife Solutions's market cap?
About 1.89B.
What is the P/E ratio of BioLife Solutions?
The trailing twelve-month P/E is 32.72. The Valuation tab shows it against the stock's own five-year range.
Does BioLife Solutions pay a dividend?
BioLife Solutions does not currently pay a regular dividend.
Is BioLife Solutions a buy according to analysts?
The consensus of 6 analysts is a Hold rating, with an average 12-month price target of 31.00, which implies 19.7% downside from the current price. This is not investment advice.
What is BioLife Solutions's StockVane Quant Rating?
The StockVane Momentum strategy currently rates BioLife Solutions a B (Buy). Twelve-month momentum in the top 19% of the universe, above its 200-day average. Not investment advice.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.